Skubitz K M, Ehresmann D D, Ducker T P
Department of Medicine, University of Minnesota Medical School, Minneapolis.
J Immunol. 1991 Jul 15;147(2):638-50.
Although most studies of protein phosphorylation have focused on intracellular protein kinases, evidence for protein kinase activity on the surface of several types of cells has been described. Evidence was recently provided for the existence of ecto-protein kinase activity on the surface of human neutrophils. Evidence for three distinct ecto-protein kinase activities was detected, one that phosphorylates endogenous surface proteins, one that phosphorylates exogenous substrates in a cAMP-independent manner and is released in the presence of substrate, and a low level of activity of one that phosphorylates exogenous Kemptide in a cAMP-dependent manner. To begin to elucidate its role in neutrophil function, we have characterized several properties of the releasable ecto-protein kinase activity on human neutrophils. This enzyme activity was inhibited by impermeant stilbene disulfonic acids, which are known to alter neutrophil function, as well as by impermeant sulfhydryl reactive agents. Enzyme activity was detectable at physiologic concentrations of Mg2+, but was higher in the presence of Mn2+. Protein kinase activity was strongly inhibited by heparin, whereas trifluoperazine, cAMP, and cGMP had little effect on kinase activity. Protein kinase activity was selectively removed from the cell surface by incubation with the ecto-kinase substrates casein and phosvitin, but the enzyme was not released by phosphatidylinositol-specific phospholipase C. Repeated exposure of neutrophils to substrate depleted ecto-protein kinase activity from the cell surface, but activity was rapidly restored by incubation in buffer lacking substrate. The released protein kinase had a Km for ATP of approximately 0.5 microM and a pH maximum between 7.0 and 7.5. At least four ecto-protein kinase substrates were detected in serum; vitronectin was identified as one of these substrates by immunoprecipitation studies. Although the exact role of ecto-protein kinase activity in neutrophil function remains undefined, the identification of vitronectin as a serum substrate suggests that it interacts with a physiologically important substrate.
尽管大多数关于蛋白质磷酸化的研究都集中在细胞内蛋白激酶上,但已有研究描述了几种细胞表面存在蛋白激酶活性的证据。最近有证据表明人中性粒细胞表面存在胞外蛋白激酶活性。检测到三种不同的胞外蛋白激酶活性,一种使内源性表面蛋白磷酸化,一种以不依赖cAMP的方式使外源性底物磷酸化并在有底物存在时释放,还有一种以依赖cAMP的方式使外源性肯普肽磷酸化的低水平活性。为了开始阐明其在中性粒细胞功能中的作用,我们已对人中性粒细胞上可释放的胞外蛋白激酶活性的几个特性进行了表征。这种酶活性受到已知会改变中性粒细胞功能的非渗透性芪二磺酸以及非渗透性巯基反应剂的抑制。在生理浓度的Mg2+下可检测到酶活性,但在Mn2+存在时活性更高。蛋白激酶活性受到肝素的强烈抑制,而三氟拉嗪、cAMP和cGMP对激酶活性影响很小。通过与胞外激酶底物酪蛋白和卵黄高磷蛋白孵育,可选择性地从细胞表面去除蛋白激酶活性,但该酶不会被磷脂酰肌醇特异性磷脂酶C释放。中性粒细胞反复暴露于底物会耗尽细胞表面的胞外蛋白激酶活性,但在缺乏底物的缓冲液中孵育可使其活性迅速恢复。释放的蛋白激酶对ATP的Km约为0.5 microM,最适pH在7.0至7.5之间。血清中至少检测到四种胞外蛋白激酶底物;通过免疫沉淀研究确定玻连蛋白是其中一种底物。尽管胞外蛋白激酶活性在中性粒细胞功能中的确切作用仍不明确,但玻连蛋白作为血清底物的鉴定表明它与一种生理上重要的底物相互作用。